Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06119178 · ClinicalTrials.gov registry record
EX-PRESS® P-50 and EX-PRESS® P-200
A clinical trial, sponsored by Alcon Research.
- Completed
- Registry status
- 122
- Enrollment target
NCT06119178 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 122 participants.
The verdict
NCT06119178 has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 122 participants
- Enrollment target
Study Summary
The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term clinical performance and safety outcomes for EX-PRESS Glaucoma Filtration Devices Models P-50 and P-200.
Interventions
- DEVICE EX-PRESS P-50 filtration device
- DEVICE EX-PRESS P-200 filtration device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2023-11-21 |
| Est. Completion | 2024-06-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06119178
The ClinicalTrials.gov registry entry for NCT06119178 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EX-PRESS P-50 filtration device is the first listed.
NCT06119178 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06119178 about?
NCT06119178 is a clinical study titled "EX-PRESS® P-50 and EX-PRESS® P-200". The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term clinical performance and safety outcomes for EX-PRESS Glaucoma Filtration Devices Models P-50 and P-200.
What is the current status of trial NCT06119178?
This trial is currently completed. The enrollment target is 122 participants. The study started on 2023-11-21. Estimated completion is 2024-06-20.
What interventions are being tested in trial NCT06119178?
The interventions under investigation include: EX-PRESS P-50 filtration device (DEVICE), EX-PRESS P-200 filtration device (DEVICE).
Who is sponsoring clinical trial NCT06119178?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.